The Ophthalmologist

Business & Profession Professional Development

07/22/2022 | Geoffrey Potjewyd | 10 min read

Barbara M. Wirostko talks about the many hats she wears in ophthalmology, and the role ARVO has had in her success

Subspecialties Glaucoma

07/01/2022 | Robert A. Van der Vaart | 6 min read

What are the benefits of incorporating MIGS into your comprehensive practice?

Subspecialties Glaucoma

06/06/2022 | Oscelle Boye | 2 min read

We share some of the most interesting recent glaucoma-focused research

Business & Profession Business and Innovation

05/27/2022 | Aleksandra Jones

Find out about a virtual event on AI in ophthalmology, featuring, among others, Emily Chew, Michael Chiang, Linda Zangwill, and Michael Abramoff

Subspecialties Glaucoma

05/24/2022 | Ken Lin | 2 min read

When I was asked about my favorite MIGS device, it was an easy question to answer: Trabectome!

Subspecialties Basic & Translational Research

05/05/2022 | Hannah C. Lamont

Disease research should embrace the biotechnology available to increase drug development success

Business & Profession Business and Innovation

04/14/2022 | Gerd Auffarth

Is there a more efficient approach to treat glaucoma patients who cannot maintain eye drop adherence?

Business & Profession Health Economics and Policy

04/07/2022 | Gregor Hawlina, Matej Beltram

An expert unpacking of the SLT ascension to first line treatment for glaucoma

Subspecialties Glaucoma

03/24/2022 | Aleksandra Jones, Oscelle Boye

What have glaucoma researchers Ningli Wang – in China – and Ted Garway-Heath – in the UK – been busy with?

Subspecialties Glaucoma

03/17/2022 | Ningli Wang

Despite pandemic-related challenges, my team have managed to make promising progress in glaucoma research, with a few major breakthroughs